| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Oct―05 |
Seasonal and COVID-19 lockdown variations in PM2.5 composition to apoptosis pathways and chemical toxicity in lung cells |
Ting-Hsuan Wu, Yu-Cheng Chen, Hong-Lin Chan, Hsiu-Chuan Chou |
| 2 |
[GO] |
2023―Aug―04 |
Towards the CSNK2 phosphoproteome - With lessons from the COVID-19 pandemic to revealing the secrets of CSNK2 and its promise as a therapeutic target |
David W. Litchfield, Laszlo Gyenis, Daniel Menyhart, Scott E. Roffey |
| 3 |
[GO] |
2023―Feb―09 |
SS148 and WZ16 inhibit the activities of nsp10-nsp16 complexes from all seven human pathogenic coronaviruses |
Fengling Li, Pegah Ghiabi, Taraneh Hajian, Martin Klima, Alice Shi Ming Li, Aliakbar Khalili Yazdi, et al. (+9) Irene Chau, Peter Loppnau, Maria Kutera, Almagul Seitova, Albina Bolotokova, Ashley Hutchinson, Sumera Perveen, Evzen Boura, Masoud Vedadi |
| 4 |
[GO] |
2022―Dec―05 |
Ferritin nanocages as efficient nanocarriers and promising platforms for COVID-19 and other vaccines development |
Aliaksandra A. Reutovich, Ayush K. Srivastava, Paolo Arosio, Fadi Bou-Abdallah |
| 5 |
[GO] |
2021―Jul―31 |
Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, pharmaceutical point of view |
Ali Najmeddin, Mina Bahrololoumi Shapourabadi, Mahdi Behdani, Farid Dorkoosh |
| 6 |
[GO] |
2021―Mar―15 |
Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate |
Wen-Hsiang Chen, Junfei Wei, Rakhi Tyagi Kundu, Rakesh Adhikari, Zhuyun Liu, Jungsoon Lee, et al. (+12) Leroy Versteeg, Cristina Poveda, Brian Keegan, Maria Jose Villar, Ana C. de Araujo Leao, Joanne Altieri Rivera, Portia M. Gillespie, Jeroen Pollet, Ulrich Strych, Bin Zhan, Peter J. Hotez, Maria Elena Bottazzi |
| 7 |
[GO] |
2020―Nov―22 |
Can food and food supplements be deployed in the fight against the COVID 19 pandemic? |
Cagla Celik, Ayse Gencay, Ismail Ocsoy |
|
